Becton Dickinson and Company (BDX)
$221.04 -$2.05 (-0.93%) 5:52 AM 12/12/24
NYSE | $USD | Medical Instruments & SuppliesStock Data
-
Market Cap
$63.61B -
Day's Range
$218.84 - $222.93 -
Volume
2,020,519 -
52 Week Low / High
$217.86 - $246.89 -
PE Ratio
37.61x -
PEG Ratio
1.01 -
Dividend Frequency
quarterly
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 9
- Strong Buy
- 6
- Buy
- 3
- Hold
- 0
- Sell
- 0
- Strong Sell
- $301.17
- Target Price
Company News
-
BD Announces New Robotics Solution to Automate, Standardize Single-Cell Research — Oct 14th, 2024
Automation-Ready Reagents Used with the Hamilton Robotics Liquid-Handler Streamlines and Helps Accelerate Lab Work Leading to Genomic Sequencing FRANKLIN LAKES, N.J., Oct. 14, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company...
-
Will Becton Dickinson (BDX) Beat Estimates Again in Its Next Earnings Report? — Oct 11th, 2024
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Becton Dickinson (BDX). This company, which is in the Zacks Medical - Dental Supplies industry, shows pote...
-
Is Becton, Dickinson and Company (NYSE:BDX) Worth US$237 Based On Its Intrinsic Value? — Oct 14th, 2024
Key Insights Becton Dickinson's estimated fair value is US$187 based on 2 Stage Free Cash Flow to Equity Becton Dickinson's US$237 share price signals that it might be 27% overvalued Our fair value estimate is 34% lower than Becton Dickinson's analyst price target of US$283 Today we'll d...
-
Will Becton Dickinson (BDX) Beat Estimates Again in Its Next Earnings Report? — Oct 11th, 2024
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Becton Dickinson (BDX). This company, which is in the Zacks Medical - Dental Supplies industry, shows pote...
-
Will Becton Dickinson (BDX) Beat Estimates Again in Its Next Earnings Report? — Oct 11th, 2024
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Becton Dickinson (BDX). This company, which is in the Zacks Medical - Dental Supplies industry, shows pote...
-
BDX Stock Up on Robotics Solution Launch to Boost Single-Cell Research — Oct 15th, 2024
Becton, Dickinson and Company BDX, popularly known as BD, announced the commercial launch of the first in a family of high-throughput, robotics-compatible reagent kits, BD OMICS-One XT Library Preparation Reagent Kits, yesterday. The automated solution from the BD and Hamilton collaboratio...
-
Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term — Oct 14th, 2024
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your pr...
-
BD Announces New Robotics Solution to Automate, Standardize Single-Cell Research — Oct 14th, 2024
Automation-Ready Reagents Used with the Hamilton Robotics Liquid-Handler Streamlines and Helps Accelerate Lab Work Leading to Genomic Sequencing FRANKLIN LAKES, N.J., Oct. 14, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company...
-
Is Becton, Dickinson and Company (NYSE:BDX) Worth US$237 Based On Its Intrinsic Value? — Oct 14th, 2024
Key Insights Becton Dickinson's estimated fair value is US$187 based on 2 Stage Free Cash Flow to Equity Becton Dickinson's US$237 share price signals that it might be 27% overvalued Our fair value estimate is 34% lower than Becton Dickinson's analyst price target of US$283 Today we'll d...
-
BD Announces New Robotics Solution to Automate, Standardize Single-Cell Research — Oct 14th, 2024
Automation-Ready Reagents Used with the Hamilton Robotics Liquid-Handler Streamlines and Helps Accelerate Lab Work Leading to Genomic Sequencing FRANKLIN LAKES, N.J., Oct. 14, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company...
-
Recent uptick might appease Becton, Dickinson and Company (NYSE:BDX) institutional owners after losing 4.2% over the past year — Oct 19th, 2024
Key Insights Given the large stake in the stock by institutions, Becton Dickinson's stock price might be vulnerable to their trading decisions 50% of the business is held by the top 21 shareholders Ownership research along with analyst forecasts data help provide a good understanding of...
-
Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term — Oct 11th, 2024
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing m...
-
Recent uptick might appease Becton, Dickinson and Company (NYSE:BDX) institutional owners after losing 4.2% over the past year — Oct 19th, 2024
Key Insights Given the large stake in the stock by institutions, Becton Dickinson's stock price might be vulnerable to their trading decisions 50% of the business is held by the top 21 shareholders Ownership research along with analyst forecasts data help provide a good understanding of...
-
BD Announces New Robotics Solution to Automate, Standardize Single-Cell Research — Oct 14th, 2024
Automation-Ready Reagents Used with the Hamilton Robotics Liquid-Handler Streamlines and Helps Accelerate Lab Work Leading to Genomic Sequencing FRANKLIN LAKES, N.J., Oct. 14, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company...
-
BDX Stock Up on Robotics Solution Launch to Boost Single-Cell Research — Oct 15th, 2024
Becton, Dickinson and Company BDX, popularly known as BD, announced the commercial launch of the first in a family of high-throughput, robotics-compatible reagent kits, BD OMICS-One XT Library Preparation Reagent Kits, yesterday. The automated solution from the BD and Hamilton collaboratio...
-
Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term — Oct 14th, 2024
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your pr...
-
Recent uptick might appease Becton, Dickinson and Company (NYSE:BDX) institutional owners after losing 4.2% over the past year — Oct 19th, 2024
Key Insights Given the large stake in the stock by institutions, Becton Dickinson's stock price might be vulnerable to their trading decisions 50% of the business is held by the top 21 shareholders Ownership research along with analyst forecasts data help provide a good understanding of...
-
BDX Stock Up on Robotics Solution Launch to Boost Single-Cell Research — Oct 15th, 2024
Becton, Dickinson and Company BDX, popularly known as BD, announced the commercial launch of the first in a family of high-throughput, robotics-compatible reagent kits, BD OMICS-One XT Library Preparation Reagent Kits, yesterday. The automated solution from the BD and Hamilton collaboratio...
-
Recent uptick might appease Becton, Dickinson and Company (NYSE:BDX) institutional owners after losing 4.2% over the past year — Oct 19th, 2024
Key Insights Given the large stake in the stock by institutions, Becton Dickinson's stock price might be vulnerable to their trading decisions 50% of the business is held by the top 21 shareholders Ownership research along with analyst forecasts data help provide a good understanding of...
-
Recent uptick might appease Becton, Dickinson and Company (NYSE:BDX) institutional owners after losing 4.2% over the past year — Oct 19th, 2024
Key Insights Given the large stake in the stock by institutions, Becton Dickinson's stock price might be vulnerable to their trading decisions 50% of the business is held by the top 21 shareholders Ownership research along with analyst forecasts data help provide a good understanding of...
-
BDX Stock Up on Robotics Solution Launch to Boost Single-Cell Research — Oct 15th, 2024
Becton, Dickinson and Company BDX, popularly known as BD, announced the commercial launch of the first in a family of high-throughput, robotics-compatible reagent kits, BD OMICS-One XT Library Preparation Reagent Kits, yesterday. The automated solution from the BD and Hamilton collaboratio...
-
BD Announces New Robotics Solution to Automate, Standardize Single-Cell Research — Oct 14th, 2024
Automation-Ready Reagents Used with the Hamilton Robotics Liquid-Handler Streamlines and Helps Accelerate Lab Work Leading to Genomic Sequencing FRANKLIN LAKES, N.J., Oct. 14, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company...
-
Is Becton, Dickinson and Company (NYSE:BDX) Worth US$237 Based On Its Intrinsic Value? — Oct 14th, 2024
Key Insights Becton Dickinson's estimated fair value is US$187 based on 2 Stage Free Cash Flow to Equity Becton Dickinson's US$237 share price signals that it might be 27% overvalued Our fair value estimate is 34% lower than Becton Dickinson's analyst price target of US$283 Today we'll d...
-
BDX Stock Up on Robotics Solution Launch to Boost Single-Cell Research — Oct 15th, 2024
Becton, Dickinson and Company BDX, popularly known as BD, announced the commercial launch of the first in a family of high-throughput, robotics-compatible reagent kits, BD OMICS-One XT Library Preparation Reagent Kits, yesterday. The automated solution from the BD and Hamilton collaboratio...
-
Is Becton, Dickinson and Company (NYSE:BDX) Worth US$237 Based On Its Intrinsic Value? — Oct 14th, 2024
Key Insights Becton Dickinson's estimated fair value is US$187 based on 2 Stage Free Cash Flow to Equity Becton Dickinson's US$237 share price signals that it might be 27% overvalued Our fair value estimate is 34% lower than Becton Dickinson's analyst price target of US$283 Today we'll d...
-
Recent uptick might appease Becton, Dickinson and Company (NYSE:BDX) institutional owners after losing 4.2% over the past year — Oct 19th, 2024
Key Insights Given the large stake in the stock by institutions, Becton Dickinson's stock price might be vulnerable to their trading decisions 50% of the business is held by the top 21 shareholders Ownership research along with analyst forecasts data help provide a good understanding of...
-
Recent uptick might appease Becton, Dickinson and Company (NYSE:BDX) institutional owners after losing 4.2% over the past year — Oct 19th, 2024
Key Insights Given the large stake in the stock by institutions, Becton Dickinson's stock price might be vulnerable to their trading decisions 50% of the business is held by the top 21 shareholders Ownership research along with analyst forecasts data help provide a good understanding of...
-
BD Announces New Robotics Solution to Automate, Standardize Single-Cell Research — Oct 14th, 2024
Automation-Ready Reagents Used with the Hamilton Robotics Liquid-Handler Streamlines and Helps Accelerate Lab Work Leading to Genomic Sequencing FRANKLIN LAKES, N.J., Oct. 14, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company...
-
BDX Stock Up on Robotics Solution Launch to Boost Single-Cell Research — Oct 15th, 2024
Becton, Dickinson and Company BDX, popularly known as BD, announced the commercial launch of the first in a family of high-throughput, robotics-compatible reagent kits, BD OMICS-One XT Library Preparation Reagent Kits, yesterday. The automated solution from the BD and Hamilton collaboratio...
-
Recent uptick might appease Becton, Dickinson and Company (NYSE:BDX) institutional owners after losing 4.2% over the past year — Oct 19th, 2024
Key Insights Given the large stake in the stock by institutions, Becton Dickinson's stock price might be vulnerable to their trading decisions 50% of the business is held by the top 21 shareholders Ownership research along with analyst forecasts data help provide a good understanding of...
-
Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term — Oct 14th, 2024
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your pr...
-
Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term — Oct 14th, 2024
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your pr...
-
Recent uptick might appease Becton, Dickinson and Company (NYSE:BDX) institutional owners after losing 4.2% over the past year — Oct 19th, 2024
Key Insights Given the large stake in the stock by institutions, Becton Dickinson's stock price might be vulnerable to their trading decisions 50% of the business is held by the top 21 shareholders Ownership research along with analyst forecasts data help provide a good understanding of...
-
Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term — Oct 11th, 2024
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing m...
-
Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term — Oct 14th, 2024
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your pr...
-
Is Becton, Dickinson and Company (NYSE:BDX) Worth US$237 Based On Its Intrinsic Value? — Oct 14th, 2024
Key Insights Becton Dickinson's estimated fair value is US$187 based on 2 Stage Free Cash Flow to Equity Becton Dickinson's US$237 share price signals that it might be 27% overvalued Our fair value estimate is 34% lower than Becton Dickinson's analyst price target of US$283 Today we'll d...
-
BD Announces New Robotics Solution to Automate, Standardize Single-Cell Research — Oct 14th, 2024
Automation-Ready Reagents Used with the Hamilton Robotics Liquid-Handler Streamlines and Helps Accelerate Lab Work Leading to Genomic Sequencing FRANKLIN LAKES, N.J., Oct. 14, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company...
-
Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term — Oct 14th, 2024
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your pr...
-
Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term — Oct 14th, 2024
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your pr...
-
Is Becton, Dickinson and Company (NYSE:BDX) Worth US$237 Based On Its Intrinsic Value? — Oct 14th, 2024
Key Insights Becton Dickinson's estimated fair value is US$187 based on 2 Stage Free Cash Flow to Equity Becton Dickinson's US$237 share price signals that it might be 27% overvalued Our fair value estimate is 34% lower than Becton Dickinson's analyst price target of US$283 Today we'll d...
-
Will Becton Dickinson (BDX) Beat Estimates Again in Its Next Earnings Report? — Oct 11th, 2024
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Becton Dickinson (BDX). This company, which is in the Zacks Medical - Dental Supplies industry, shows pote...
-
Recent uptick might appease Becton, Dickinson and Company (NYSE:BDX) institutional owners after losing 4.2% over the past year — Oct 19th, 2024
Key Insights Given the large stake in the stock by institutions, Becton Dickinson's stock price might be vulnerable to their trading decisions 50% of the business is held by the top 21 shareholders Ownership research along with analyst forecasts data help provide a good understanding of...
-
BDX Stock Up on Robotics Solution Launch to Boost Single-Cell Research — Oct 15th, 2024
Becton, Dickinson and Company BDX, popularly known as BD, announced the commercial launch of the first in a family of high-throughput, robotics-compatible reagent kits, BD OMICS-One XT Library Preparation Reagent Kits, yesterday. The automated solution from the BD and Hamilton collaboratio...
-
BDX Stock Up on Robotics Solution Launch to Boost Single-Cell Research — Oct 15th, 2024
Becton, Dickinson and Company BDX, popularly known as BD, announced the commercial launch of the first in a family of high-throughput, robotics-compatible reagent kits, BD OMICS-One XT Library Preparation Reagent Kits, yesterday. The automated solution from the BD and Hamilton collaboratio...
-
BD Announces New Robotics Solution to Automate, Standardize Single-Cell Research — Oct 14th, 2024
Automation-Ready Reagents Used with the Hamilton Robotics Liquid-Handler Streamlines and Helps Accelerate Lab Work Leading to Genomic Sequencing FRANKLIN LAKES, N.J., Oct. 14, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company...
-
Is Becton, Dickinson and Company (NYSE:BDX) Worth US$237 Based On Its Intrinsic Value? — Oct 14th, 2024
Key Insights Becton Dickinson's estimated fair value is US$187 based on 2 Stage Free Cash Flow to Equity Becton Dickinson's US$237 share price signals that it might be 27% overvalued Our fair value estimate is 34% lower than Becton Dickinson's analyst price target of US$283 Today we'll d...
-
Is Becton, Dickinson and Company (NYSE:BDX) Worth US$237 Based On Its Intrinsic Value? — Oct 14th, 2024
Key Insights Becton Dickinson's estimated fair value is US$187 based on 2 Stage Free Cash Flow to Equity Becton Dickinson's US$237 share price signals that it might be 27% overvalued Our fair value estimate is 34% lower than Becton Dickinson's analyst price target of US$283 Today we'll d...
-
Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term — Oct 11th, 2024
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing m...
-
Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term — Oct 14th, 2024
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your pr...
-
Recent uptick might appease Becton, Dickinson and Company (NYSE:BDX) institutional owners after losing 4.2% over the past year — Oct 19th, 2024
Key Insights Given the large stake in the stock by institutions, Becton Dickinson's stock price might be vulnerable to their trading decisions 50% of the business is held by the top 21 shareholders Ownership research along with analyst forecasts data help provide a good understanding of...
Portfolio
Comprised of 1 portfolios